Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
Diality Inc. · NCT06613568
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–80 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 5
- Study start
- October 6, 2025
- Record last updated
- July 6, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to evaluate the safety and efficacy of the Moda-flx Hemodialysis System™ when used Under Professional Care Settings by trained individuals and At Home by trained Participants and Care Partners
Being studied: Moda-flx Hemodialysis System™
Conditions: End Stage Kidney Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Are between 18 and 80 years of age and Care Partner is at least 18 years of age at the time of signing consent.
- Have a diagnosis of end stage kidney disease (ESKD) adequately treated by maintenance dialysis (defined as achieving a spKt/V ≥ 1.2 OR stdKt/V ≥ 2.1) and be deemed stable by their treating nephrologist prior to the end of the Screening Period
- Have a well-functioning and stable vascular access (tunneled central venous catheter arteriovenous fistula, or graft) that allows a blood flow of at least 300 ml/min prior to the end of Screening
- Can successfully complete a Skills and Comprehension Assessment with a Care Partner prior to the completion of the Training Period.
Exclusion Criteria
- Hgb level of \< 9 g/dL at Screening
- Symptomatic intradialytic hypotension requiring medical intervention (ultrafiltration turned off, bolus of fluid) in at least two treatments during the Run-In period defined as:
- Persistent pre-dialysis sitting SBP \< 100 mmHg despite medical therapy,
- Nadir intradialytic Systolic Blood Pressure (SBP) \< 90 mmHg, if Subject's pre-HD SBP \< 160 mmHg
- Nadir intradialytic SBP \< 100 mmHg if Subject's pre-HD SBP ≥ 160 mmHg
- Documented history of non-adherence to dialysis therapy that would prevent successful completion of the study
- Participant had an average ultrafiltration rate > 13 mL/kg/hour during the last 2 weeks prior to Screening, per medical records.
- Had a significant cardiovascular adverse event within the last 90 days prior to Screening.
Recruiting US locations
North America Research Institute
San Dimas, CA 91773
Site contact: Molly Way · (800) 797-1695 · mpruitt@nariresearch.com
New York Kidney Hypertension Medicine
New Hyde Park, NY 11040
Site contact: Muhammad Qureshi, MD · 718-483-7407 · mqureshi@atlanticdialysis.com
Nephrology Associates of Knoxville
Knoxville, TN 37920
Site contact: Benjamin Brooks · 865-323-3382 · benjamin.brooks@dciinc.org
aQua Research Institute, LLC
Houston, TX 77058
Site contact: Rhea Sharma · 281-939-6516 · rheas@aqua-ri.com
University of Washington
Seattle, WA 98104
Site contact: Lori Linke · linkel@uw.edu
Study contacts (from the official record)
- Michael Gastauer · 949-916-5851 · HomeTrial@Diality.com